Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$793M |
| 2 |
Microsoft
MSFT
|
+$777M |
| 3 |
Coca-Cola
KO
|
+$755M |
| 4 |
Apple
AAPL
|
+$744M |
| 5 |
NVIDIA
NVDA
|
+$718M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Real Estate ETF
VNQ
|
+$251M |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$247M |
| 3 |
Oracle
ORCL
|
+$228M |
| 4 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$176M |
| 5 |
MRO
Marathon Oil Corporation
MRO
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.59% |
| 2 | Financials | 12.77% |
| 3 | Consumer Discretionary | 9.88% |
| 4 | Healthcare | 9.85% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Pliant Therapeutics
PLRX
$64.4M
| $6.05M | ﹤0.01% |
459,384
+2,721
| +0.6% | +$37.1K |
|
2252
ATS Corp
ATS
$2.69B
| $6.05M | ﹤0.01% |
198,402
+5,525
| +3% | +$168K |
|
2253
Independent Bank Corp
IBCP
$793M
| $6M | ﹤0.01% |
172,346
+1,256
| +0.7% | +$44.6K |
|
2254
Universal Insurance Holdings
UVE
$1.23B
| $5.98M | ﹤0.01% |
283,863
-63,532
| -18% | -$1.33M |
|
2255
Aurinia Pharmaceuticals
AUPH
$1.87B
| $5.97M | ﹤0.01% |
665,087
-78,963
| -11% | -$644K |
|
|
STKL
2256
DELISTED
SunOpta
STKL
| $5.97M | ﹤0.01% |
774,918
+15,049
| +2% | +$106K |
|
|
SNBR
2257
DELISTED
Sleep Number
SNBR
| $5.96M | ﹤0.01% |
390,966
-204,846
| -34% | -$3.18M |
|
|
CBL
2258
CBL Properties
CBL
$1.81B
| $5.96M | ﹤0.01% |
202,574
-67,315
| -25% | -$1.91M |
|
2259
GrafTech
EAF
$195M
| $5.95M | ﹤0.01% |
343,992
-163,213
| -32% | -$3.04M |
|
2260
Baytex Energy
BTE
$3.12B
| $5.94M | ﹤0.01% |
2,308,311
+118,206
| +5% | +$336K |
|
2261
Orthofix Medical
OFIX
$496M
| $5.93M | ﹤0.01% |
339,531
+14,724
| +5% | +$256K |
|
|
TRST
2262
Trustco Bank Corp NY
TRST
$975M
| $5.9M | ﹤0.01% |
177,238
+6,867
| +4% | +$239K |
|
2263
Enliven Therapeutics
ELVN
$4.15B
| $5.89M | ﹤0.01% |
261,888
+6,611
| +3% | +$171K |
|
2264
monday.com
MNDY
$3.76B
| $5.87M | ﹤0.01% |
24,936
+897
| +4% | +$248K |
|
|
ZIMV
2265
DELISTED
ZimVie
ZIMV
| $5.86M | ﹤0.01% |
419,899
-126,603
| -23% | -$1.82M |
|
2266
Kanzhun
BZ
$7.36B
| $5.85M | ﹤0.01% |
423,816
+53,225
| +14% | +$783K |
|
2267
Funko
FNKO
$323M
| $5.85M | ﹤0.01% |
436,555
+154,519
| +55% | +$1.82M |
|
2268
indie Semiconductor
INDI
$716M
| $5.8M | ﹤0.01% |
1,431,093
+112,793
| +9% | +$463K |
|
2269
FIGS
FIGS
$1.82B
| $5.79M | ﹤0.01% |
935,182
-131,545
| -12% | -$767K |
|
2270
British American Tobacco
BTI
$128B
| $5.79M | ﹤0.01% |
159,363
+27,492
| +21% | +$993K |
|
2271
Horizon Bancorp
HBNC
$1.06B
| $5.79M | ﹤0.01% |
359,247
+8,266
| +2% | +$139K |
|
2272
AMC Global Media
AMCX
$479M
| $5.77M | ﹤0.01% |
583,237
-395,903
| -40% | -$3.5M |
|
2273
Orrstown Financial Services
ORRF
$859M
| $5.77M | ﹤0.01% |
157,596
-433
| -0.3% | -$16.5K |
|
2274
NB Bancorp
NBBK
$1.01B
| $5.77M | ﹤0.01% |
319,436
+4,138
| +1% | +$79.5K |
|
2275
First Watch Restaurant Group
FWRG
$771M
| $5.77M | ﹤0.01% |
309,851
+58,448
| +23% | +$1.03M |
|
Similar funds
Charles Schwab's Q4 2024 Portfolio in Review
As of Q4 2024, Charles Schwab held 3,563 positions worth $542B, up 3.5% from $524B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Charles Schwab deployed $17.7B of net new capital in Q4 2024, opening 62 new positions and adding to 2,296 existing holdings. Its largest new stake was Janus Henderson AAA CLO ETF: 3,465,261 shares worth $176M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard Mortgage-Backed Securities ETF, an estimated $247M trimmed.
- Charles Schwab's largest Q4 2024 buy was Janus Henderson AAA CLO ETF: 3,465,261 shares worth $176M.
- Charles Schwab added most to Amgen in Q4 2024, an estimated $793M increase.
- Charles Schwab's biggest Q4 2024 reduction was Vanguard Mortgage-Backed Securities ETF, cutting an estimated $247M.
- Charles Schwab fully exited Vanguard Real Estate ETF in Q4 2024, selling an estimated $251M.
- Charles Schwab's ten largest holdings make up 23% of its $542B portfolio in Q4 2024.
- Charles Schwab opened 62 new positions and closed 70 in Q4 2024.
- Charles Schwab's portfolio value rose 3.5% quarter-over-quarter to $542B.
Based on Charles Schwab's 13F filing for Q4 2024, filed 6 Feb 2025.